-: ()
Los medicamentos GLP-1, que incluyen Ozempic, Wegovy, Mounjaro y Zepbound, han demostrado ser altamente efectivos para perder peso
Jennifer B Green, Amy K Mottl, George Bakris, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Masaomi Nangaku, Peter Rossing, Charlie Scott, Alain Gay, Rajiv Agarwal
References: IQVIA LAAD pharmacy claims data, US Market Access Strategy Consulting analysis Eli Lilly Tightens Access to Diabetes Drug, Frustrating Some People with Obesity, STAT News New Demand in an Old Market Read part 2 of this blog series to learn how the launch of Mounjaro transformed the GLP-1 market and led to the emergence of a new type of patient access profile thats challenging todays traditional diabetes care paradigm
This stack is often used as part of a routine that includes progressive overload, higher protein intake, and a structured workout plan
Dhariwal, M., Rasmussen, M